MARKET

TCMD

TCMD

Tactile Systems
NASDAQ
8.04
+0.50
+6.63%
After Hours: 8.19 +0.15 +1.87% 17:08 09/28 EDT
OPEN
7.60
PREV CLOSE
7.54
HIGH
8.14
LOW
7.60
VOLUME
1.08M
TURNOVER
0
52 WEEK HIGH
46.41
52 WEEK LOW
6.28
MARKET CAP
161.86M
P/E (TTM)
-5.1499
1D
5D
1M
3M
1Y
5Y
Tactile Medical to Release Third Quarter of Fiscal Year 2022 Financial Results on November 7, 2022
MINNEAPOLIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, ...
GlobeNewswire · 2d ago
Tactile Medical to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, ...
GlobeNewswire · 09/06 11:30
--Oppenheimer Adjusts Price Target on Tactile Systems Technology to $18 From $35, Maintains Outperform Rating
--Oppenheimer Adjusts Price Target on Tactile Systems Technology to $18 From $35, Maintains Outperform Rating
MT Newswires · 08/02 09:06
--Piper Sandler Adjusts Price Target on Tactile Systems Technology to $25 From $28, Reiterates Overweight Rating
--Piper Sandler Adjusts Price Target on Tactile Systems Technology to $25 From $28, Reiterates Overweight Rating
MT Newswires · 08/02 05:47
Tactile Systems Technology (TCMD) Reports Q2 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 12.50% and 4.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/01 21:55
Recap: Tactile Systems Tech Q2 Earnings
Tactile Systems Tech (NASDAQ:TCMD) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Tactile Systems Tech reported in-line EPS of $-0.15 versus an estimate of $-0.15.
Benzinga · 08/01 21:26
BRIEF-Tactile Systems Technology Q2 Revenue Up 17% To $59.6 Mln
BRIEF-Tactile Systems Technology Q2 Revenue Up 17% To $59.6 Mln
Reuters · 08/01 21:23
Tactile Systems Tech Q2 EPS $(0.23) Misses $(0.15) Estimate, Sales $59.60M Beat $56.88M Estimate
Tactile Systems Tech (NASDAQ:TCMD) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 428.57 percent decrease over earnings of $0.07 per
Benzinga · 08/01 20:26
More
About TCMD
Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.